SEC Form 4 · accession 0001179110-15-003332
ABBOTT LABORATORIES · ABT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael J Warmuth
Officer — Executive Vice President
Period of report
Feb 20, 2015
Accepted (ET)
Feb 24, 2015 · 5:44 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000001800
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option (right to buy)F1 | $47.00 | Feb 20, 2015 | A | 181,034 | A | Feb 20, 2016 | Feb 19, 2025 | Common shares | 181,034 | 181,034 | D |
Explanation of responses
- F1Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 60,345 on 2/20/16, 60,344 on 2/20/17, and 60,345 on 2/20/18.